Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 44 to 63 of 75 < previous   next >
TitleAuthor(s)Issue DateViews
 
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection
Proceeding/Conference:Hepatology
Yuen, RMFKim, JAverett, DWong, DKHKim, CRKerr, BNgai, WSYuen, JCHLai, CL
2004
143
 
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
Proceeding/Conference:Antiviral Research
Yuen, RMFKim, JWong, DKHNgai, WSYuen, JCHLai, CL
2003
61
 
Pin1 over-expression and β-catenin gene mutations are distinct oncogenic events in human hepatocarcinogenesis.
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2003
Pang, RWCYuen, JCHYuen, RMFLai, CLKwong, YLTse, EWC
2003
93
 
Predictive model for fibrosis and cirrhosis in chronic hepatitis B using liver stiffness measurement
Proceeding/Conference:Hepatology
Fung, JYYLai, CLFong, DYTYuen, JCHWong, DKHYuen, RMF
2007
115
 
Predictive value of HBV DNA levels at frequent time points during early and maintenance phase of 5-year laminudine and mutational profiles of reverse transcriptase (RT) and surface (S) genes
Proceeding/Conference:Hepatology
Yuen, RMFWong, DKHFung, JYYYuen, JCHLai, CL
2006
148
 
Prevalence and significance of hepatitis GB virus-C/hepatitis G virus viremia in a large cohort of patients with chronic hepatitis B infection, with chronic hepatitis C infection, and on renal replacement therapy in Hong Kong
Journal:Digestive Diseases and Sciences
Yuen, MFChan, TMTerence PokSiu, YIPYuen, JCHHo, SKNLai, CL
2002
129
 
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: A study of a large blood donor population
Journal:Gut
Yuen, MFLee, CKWong, DKHFung, JHung, IHsu, ABut, DYKCheung, TKChan, PYuen, JCHFung, FKCSeto, WKLin, CKLai, CL
2010
166
 
Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
Proceeding/Conference:Hepatology
Fung, JYYLai, CLTanaka, YMizokami, MYuen, JCHWong, DKHYuen, RMF
2007
89
 
Profound reduction of HBV covalently closed circular DNA with long-term nucleoside/tide analogue therapy
Proceeding/Conference:Hepatology
Lai, CLWong, DKHIp, PKopaniszen, MSeto, WKFung, JHuang, FYLee, BPCullaro, GWu, CHCheng, CYuen, JCHNgai, VYuen, MF
2014
124
 
Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications
Journal:Gut
Yuen, MFYuan, HJWong, DKHYuen, JCHWong, WMChan, AOOWong, BCYLai, KCLai, CL
2005
153
 
Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma
Journal:Journal of Hepatology
Wong, DKHYuen, MFPoon, RTPYuen, JCHFung, JLai, CL
2006
189
 
A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B
Journal:Antiviral Therapy
Yuen, MFKim, JKim, CRNgai, VYuen, JCHMin, CKang, HMShin, BSYoo, SDLai, CL
2006
 
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable cccDNA
Proceeding/Conference:Hepatology
Lai, CLWong, DKHYuen, JCHWu, CHCheng, CTKNgai, WSKopaniszen, MSeto, WKWFung, JYYYuen, RMF
2017
60
 
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Journal:Journal of Hepatology
Lai, CLWong, DKHIp, PCPKopaniszen, MSeto, WKWFung, JYYHuang, FYLee, BCullaro, GChong, CKWu, CHCheng, CTKYuen, JCHNgai, WSYuen, RMF
2017
108
 
Reduction of hepatitis B core related antigen by long term nucleoside nucleotide analogue therapy and its correlation with intrahepatic HBV DNA reduction
Proceeding/Conference:Hepatology International
Wong, DKopaniszen, MSeto, WKFung, JHung, IYoung, JLPYuen, JCHNgai, VWSYuen, MFLai, CL
2015
249
 
Risk factors and post-resection independent predictive score for the recurrence of hepatitis B-related hepatocellular carcinoma
Proceeding/Conference:Hong Kong Medical Journal
Hung, IFNWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKFung, JYYChan, ACYYuen, JCHTiu, RChoi, OLai, CLYuen, MF
2015
46
 
Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
Journal:PLoS ONE
Hung, FNIWong, DKHPoon, RTPFong, DYTChui, AHWSeto, WKWFung, JYYChan, ACYYuen, JCHTiu, TMRJCHOI, MYOLai, CLYuen, RMF
2016
89
 
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels
Journal:Gut
Yuen, MFTanaka, YShinkai, NPoon, RTBut, DYKFong, DYTFung, JWong, DKHYuen, JCHMizokami, MLai, CL
2008
131
 
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesis
Proceeding/Conference:Journal of Hepatology
Yuen, RMFTanaka, YShinkai, NPoon, RTPFung, JYYWong, DKHYuen, JCHMizokami, MLai, CL
2007
 
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: A case control study
Journal:Carcinogenesis
Yuen, MFTanaka, YMizokami, MYuen, JCHWong, DKHYuan, HJSum, SMChan, AOOWong, BCYLai, CL
2004
178
Showing results 44 to 63 of 75 < previous   next >